Tangier Disease: Exploring Advances in Colorectal Cancer Treatment
In the realm of medical oncology, treatment advances continually reshape patient outcomes and therapeutic approaches. One significant development in colorectal cancer treatment involves the use of sulindac. This non-steroidal anti-inflammatory drug (NSAID) exhibits promising potential in both prevention and therapy. The drug’s anti-inflammatory properties, coupled with its ability to modulate tumor pathways, have sparked significant…